European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease
Top Cited Papers
- 1 January 2012
- journal article
- practice guideline
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 54 (1) , 136-160
- https://doi.org/10.1097/mpg.0b013e31821a23d0
Abstract
Objective: Diagnostic criteria for coeliac disease (CD) from the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) were published in 1990. Since then, the autoantigen in CD, tissue transglutaminase, has been identified; the perception of CD has changed from that of a rather uncommon enteropathy to a common multiorgan disease strongly dependent on the haplotypes human leukocyte antigen (HLA)‐DQ2 and HLA‐DQ8; and CD‐specific antibody tests have improved.Methods: A panel of 17 experts defined CD and developed new diagnostic criteria based on the Delphi process. Two groups of patients were defined with different diagnostic approaches to diagnose CD: children with symptoms suggestive of CD (group 1) and asymptomatic children at increased risk for CD (group 2). The 2004 National Institutes of Health/Agency for Healthcare Research and Quality report and a systematic literature search on antibody tests for CD in paediatric patients covering the years 2004 to 2009 was the basis for the evidence‐based recommendations on CD‐specific antibody testing.Results: In group 1, the diagnosis of CD is based on symptoms, positive serology, and histology that is consistent with CD. If immunoglobulin A anti‐tissue transglutaminase type 2 antibody titers are high (>10 times the upper limit of normal), then the option is to diagnose CD without duodenal biopsies by applying a strict protocol with further laboratory tests. In group 2, the diagnosis of CD is based on positive serology and histology. HLA‐DQ2 and HLA‐DQ8 testing is valuable because CD is unlikely if both haplotypes are negative.Conclusions: The aim of the new guidelines was to achieve a high diagnostic accuracy and to reduce the burden for patients and their families. The performance of these guidelines in clinical practice should be evaluated prospectively.Keywords
This publication has 143 references indexed in Scilit:
- Usefulness of Small-bowel Mucosal Transglutaminase-2 Specific Autoantibody Deposits in the Diagnosis and Follow-up of Celiac DiseaseJournal of Clinical Gastroenterology, 2010
- Celiac Disease without Villous Atrophy in Children: A Prospective StudyThe Journal of Pediatrics, 2010
- Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue TransglutaminaseJournal of Pediatric Gastroenterology and Nutrition, 2010
- Influence of Age and Genetic Risk on Anti‐tissue Transglutaminase IgA TitersJournal of Pediatric Gastroenterology and Nutrition, 2009
- Diagnosing Mild Enteropathy Celiac Disease: A Randomized, Controlled Clinical StudyGastroenterology, 2009
- A Report on the International Transglutaminase Autoantibody Workshop for Celiac DiseaseAmerican Journal of Gastroenterology, 2008
- Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of AgeJournal of Pediatric Gastroenterology and Nutrition, 2008
- Gluten‐dependent Small Bowel Mucosal Transglutaminase 2–specific IgA Deposits in Overt and Mild Enteropathy Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21Nature Genetics, 2007
- Low specificity of anti‐tissue transglutaminase antibodies in patients with primary biliary cirrhosisJournal of Clinical Laboratory Analysis, 2006